[seopress_breadcrumbs]

Strategic Insights on Venture Investors with David Beisel

•

Strategic Insights on Venture Investors with David Beisel

In this episode, I interview Co-Founder and Partner of NextView Ventures David Beisel. NextView Ventures focuses on consumer web, mobile, SaaS and other Internet startups.

During our interview, I probe David about the strategic nuances and details of starting a venture fund and the important elements of searching for other investors/growing your fund.

Listen to the Entire Interview here – Check out this episode!

————–

Interested in the Future of Humanity and the Ramifications of Emerging Tech? Sentient Potential Covers the Ethical Considerations and Future Projections at the Crossroads of Technology and Consciousness:

https://danfaggella.com/.com

Recommended from Emerj

Read more

Design as the Enterprise Supply‑Chain Moat

This article is sponsored by Optilogic and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Enterprise supply chains are entering a phase where traditional planning models no longer protect the business. As forecasting and…

•

Emerj|Chubb|AI use cases

Read more

AI at Chubb

Chubb Limited is a global property and casualty insurer that serves multinational corporations, mid-size and small businesses, and high-net-worth individuals across dozens of countries. In its December 2025 investor presentation, the company reported $90 billion in total capital, an AA rating from S&P, and $56.4 billion in trailing total premium revenue, ranking seventh among global…

•

Read more

From Connected Agents to Collective Intelligence

This interview analysis is sponsored by Outshift by Cisco and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Agentic AI is running into the same wall across enterprises: agents drift, deadlock, and propagate…

•

Read more

Unified Context as the Missing Foundation for Enterprise AI

This article is sponsored by Arango and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Scalable AI requires coherent, connected context, since no model can compensate for an enterprise architecture that presents multiple versions…

•

Emerj|UpperEdge|Rainbow Data Contracts

Read more

The New Playbook for Enterprise AI Contracts

This article is sponsored by UpperEdge and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Enterprise AI spend and outcomes are diverging, and available data quantify the gap. The difficulty for CIOs is whether…

•

Emerj | AI at Moderna

Read more

AI at Moderna

Moderna is a Cambridge, Massachusetts-based biotechnology company that has built its operating model around messenger RNA (mRNA), a technology it has used to develop vaccines and therapeutics for infectious disease, oncology, and rare disease. The company is best known for Spikevax, its COVID-19 vaccine, but it now markets three approved products and is advancing a…

•

Ed_Dialpad_Header Image_Longform Article.jpg

Read more

Why Agentic AI Is Becoming the Defining Capability in Modern CX

This article is sponsored by Dialpad and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Agentic AI is becoming the defining capability in modern customer service enterprises, which are under increasing pressure to fix…

•

Read more

The Conditions That Turn AI Pilots Into Enterprise Value

This article is sponsored by HTEC and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. AI adoption is rising, but the workflows that generate ROI remain largely unchanged — a pattern indicating that most…

•

From Experimentation to Clinical-grade AI in Healthcare - with Alex Tyrell Wolters Kluwer

Read more

From Experimentation to Clinical-grade AI in Healthcare

For years, enterprise AI strategy has operated on a simple assumption that once the models get good enough, adoption will follow. That assumption is now being tested — and failing. Model capability has, by most measures, arrived. What hasn't arrived yet are the infrastructure, security posture, and workflow architecture needed to enable autonomous systems to…

•

Emerj |HTEC AI in Data Engieering

Read more

Enterprise AI in Practice and How Leading Firms Move from Strategy to Production

This article is sponsored by HTEC and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Operating models, workflows, and software development processes were never designed for AI — resulting in stalled initiatives, lost momentum,…

•

Human-Centered AI Development Strategies for CPG Leaders - with Shaje Ganny of Procter & Gamble

Read more

Human-Centered AI Development Strategies for CPG Leaders – with Shaje Ganny of Procter & Gamble

CPG leaders need AI systems that start with concrete operating constraints and end with measurable outcomes vetted for company, consumer, and community impact. MIT’s The GenAI Divide: State of AI in Business 2025 found that 95% of enterprise generative AI pilots did not produce measurable financial impact, a result that highlights how often companies launch…

•

Emerj ODAIA_Article Closing the Execution Gap in Pharma’s Commercial Model

Read more

Closing the Execution Gap in Pharma’s Commercial Model

This article is sponsored by ODAIA and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Pharma is leaving revenue and patients on the table because strategy isn't reaching the field with the speed or…

•